Many investors like to look for momentum in stocks, but this can be very tough to define. There is great debate regarding which metrics are the best to focus on in this regard, and which are not really quality indicators of future performance. Fortunately, with our new style score systemwe have identified the key statistics to pay close attention to and thus which stocks might be the best for momentum investors in the near term.

This method discovered several great candidates for momentum-oriented investors, but today let’s focus in on LeMaitre Vascular, Inc. (LMAT Quick QuoteLMAT - Free Report) as this stock is looking especially impressive right now. And while there are numerous ways in which this company could be a great choice, we have highlighted three of the most vital reasons for LMAT’s status as a solid momentum stock below:

Short Term Price Change for LeMaitre Vascular

A great place to look for finding momentum stocks is by inspecting short term price activity. This can help to reflect the current interest in a stock and if buyers or sellers have the upper hand right now. It is especially useful to compare it to the industry as this can help investors pinpoint the top companies in a particular area.

With a one week price change of 11.47% compared to an industry average of -1.49%, LMAT is certainly well-positioned in this regard. The stock is also looking quite well from a longer time frame too, as the four week price change compares favorably with the industry at large as well.

Quarter EPS Estimate Change for LeMaitre Vascular

While looking at price performance or full year earnings can be essential to understanding a momentum stock, you shouldn’t forget about the current quarter EPS and the trend in estimates there. This change can signal how a stock might perform in the next earnings season which is obviously vital for momentum investors.

Right now, LMAT is seeing a nice trend over the past month when it comes to this quarter’s earnings estimate projections. In the time frame, EPS estimates for LeMaitre Vascularhave gone up by 43.64% compared to an industry average move of 3.15%, suggesting that not only is LMAT heading in the right direction, but it is seeing an increase relative to the industry too.

LMAT Earnings Estimate Revisions Moving in the Right Direction

While the great momentum factors outlined in the preceding paragraphs might be enough for some investors, we should also take into account broad earnings estimate revision trends. A nice path here can really help to show us a promising stock, and we have actually been seeing that with LMAT as of late too.

Over the past two months, 4 earnings estimate have gone higher compared to none lower for the full year, while we are also seeing that 4 estimates have moved upwards with no downward revisions for the next year time frame too. These revisions have helped to boost the consensus estimate as two months ago LMAT was expected to post earnings of 48 cents/share for the full year, though today it looks to have EPS of 55 cents for the full year now, representing a solid increase which is something that should definitely be welcomed news to would-be investors.

LEMAITRE VASCLR Price and Consensus

LEMAITRE VASCLR Price and Consensus | LEMAITRE VASCLR Quote

Bottom Line

Given these factors, investors shouldn’t be surprised to note that we have LMAT as a security with a Zacks Rank #2 (Buy) and a Momentum Score of ‘B’.You can seethe complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

So if you are looking for a fresh pick that has potential to move in the right direction, definitely keep LMAT on your short list as this looks be a stock that is very well-positioned to soar in the near term.

Confidential from Zacks

Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>